Related Experiment Video
Updated: Sep 16, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Current state of microbiota clinical applications in neonatal and pediatric bacterial infections
Thanh Thien Le1, Tram Ngoc Hoang2, Dylan Huy Do3,4
1Vinmec-VinUni Institute of Immunology, College of Health Science, VinUniversity, Hanoi, Vietnam.
Insights
The pediatric microbiota is vital for immune defense against bacterial infections. Maintaining a balanced gut microbiome is key for preventing infections and improving outcomes in children, especially those who are vulnerable.
Area of Science:
- Microbiology
- Pediatric Immunology
- Infectious Diseases
Background:
- The gut microbiota is critical for immune system development and protection against infections in infants and children.
- An immature or disrupted microbiota increases susceptibility to bacterial infections, particularly in vulnerable populations like premature infants and immunocompromised children.
Purpose of the Study:
- To review clinical trials on the role of the microbiota in neonatal and pediatric bacterial infections.
- To examine the impact of microbiota composition on infection risk, treatment responses, and adverse effects in children.
- To evaluate the potential of microbiota-restorative interventions for preventing and treating pediatric bacterial infections.
Main Methods:
- Systematic review of original research articles published between 2000 and May 2024.
- Focus on studies concerning the microbiota and bacterial infections in neonates and children.
- Analysis of microbiome signatures in various body sites (gut, oral, nasopharynx) and their association with infection.
Main Results:
- Microbiota composition significantly influences infection risk, treatment efficacy, and side effects of therapies like antibiotics and chemotherapy.
- Dysbiosis, often caused by antibiotic exposure or medical treatments, leads to an overgrowth of harmful bacteria, including antibiotic-resistant strains.
- Microbiota-restorative therapies (e.g., probiotics, fecal microbiota transplantation) show promise in enhancing resilience against bacterial infections.
Conclusions:
- A balanced microbiota is essential for preventing bacterial infections in children, especially in premature and immunocompromised individuals.
- Judicious antibiotic use and exploration of microbiota-based therapies are crucial for mitigating long-term disruptions and improving pediatric health outcomes.
- The microbiota holds significant potential for predicting and treating bacterial infections in pediatric populations.
Abstract:
The microbiota plays a crucial role in pediatric health by shaping immune development and influencing infection susceptibility. In infants and children, an immature microbiota may compromise immune defense, increasing the risk of bacterial infections. This review evaluates clinical trials on the microbiota's role in neonatal and pediatric bacterial infections, including sepsis, infections in pediatric cancer patients, and Clostridioides difficile-associated dysbiosis. We summarized original research articles published from 2000 to May 2024 on the microbiota and bacterial infections in neonates and children. A balanced microbiota is essential for infection prevention, particularly in premature infants and immunocompromised children. Studies of microbiome signatures in the gut, oral cavity, and nasopharynx have highlighted how microbiota composition influences infection risk, treatment response, and adverse effects from antibiotics and chemotherapy. Disruptions from antibiotic exposure, chemotherapy, and hematopoietic stem cell transplantation frequently lead to dysbiosis, characterized by depletion of commensal bacteria and overgrowth of pathobionts, including antibiotic-resistant strains such as C. difficile. Conversely, microbiota-restorative interventions, such as probiotics and fecal microbiota transplantation, show promise in reducing bacterial infections by enhancing microbial resilience. The microbiota plays a critical role in predicting and potentially treating bacterial infections in children. While antibiotics remain essential, their widespread use has significant consequences for microbiota health. Striking a balance between effective infection control and microbiota preservation is crucial, particularly in vulnerable pediatric populations. Implementing judicious antibiotic use and exploring microbiota-based therapies may mitigate long-term microbiota disruptions, ultimately improving infection outcomes and overall pediatric health.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
History of Microbiology
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Applications of Molecular Taxonomy
Key Techniques in Microbiology

